Blogs
Stay current with product and data science updates, industry and technology trends, and culture updates from the CancerLinQ team.
Updated August 26, 2021 - Demographics of Patients with Cancer and COVID-19 Disease
CancerLinQ Data
Forty-seven of the CancerLinQ practices providing regular data updates also provided testing information for and/or diagnostic reports of COVID-19…
Unlocking data. Discovering trends. Improving care.
Experience the latest from CancerLinQ Insights: Clinical Data Dashboards
EMPLOYEE SPOTLIGHT: Dr. Danielle Dell Potter
Meet Dr. Danielle Dell Potter, Principal Scientist and Head of Real World Evidence at CancerLinQ.
From One Patient to Millions: Making All the Right Connections
By Jack Aiello
How CancerLinQ uses real-world data to better inform the cancer patient journey
The Future of CancerLinQ - CEO Perspective
By Sean Khozin, MD, MPH
A patient-centered and equitable approach to transforming cancer care and research
Impact of COVID-19 Disease on Oncology Practice: Targeted Therapies Used in Lung Cancer
COVID-19 Surveillance Report
Trends in prescription and/or administration of targeted therapies used in lung cancer by month since January 2019
Impact of COVID-19 Disease on Oncology Practice: Aromatase inhibitors and tamoxifen
CancerLinQ Data
Trends in prescription and/or administration of aromatase inhibitors and tamoxifen by month since January 2019
Impact of COVID-19 Disease on Oncology Practice: Chemotherapy Drug for Breast, Colon and Lung Cancer
COVID-19 Surveillance Report
This is the second in a series of reports on the impacts of COVID-19 disease on the practice of oncology as observed through de-identified CancerLinQ…
Update on demographic data on COVID-19 patients in CancerLinQ
CancerLinQ Data
UPDATED DATA: CancerLinQ continues to monitor COVID diagnoses among active cancer patients in our database of 1.5 million total cancer patients
